Teneglee 20 Tablets contain teneligliptin which is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
Dosage Form
Tablet
Route of Administration
Oral
Composition
Each film-coated tablet contains:
Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin I.P. 20 mg
Excipients q.s.
Indications
Teneglee 20 Tablets are indicated for the treatment of Type 2 Diabetes Mellitus as a monotherapy adjunct to diet and exercise.
Storage
Store in a dry place at a temperature not exceeding 30°C. Protect from light.
Precautions
Teneglee 20 Tablets should be used with caution in patients with kidney, liver, or heart disorders. Regular monitoring of blood glucose levels is recommended during treatment. Patients should be alert for symptoms of hypoglycemia, especially when used with other antidiabetic medicines. The medicine should be taken only under medical supervision.
Presentation
10 × 15 Tablets.
GLOBAL HORIZONS
Your Efforts Extended Through a Partnership That's Better Together
